Pharma Giants Turn Human Health into a Monthly Subscription #
The body is the temple of the Holy Spirit, yet the modern pharmaceutical industry increasingly treats it as a recurring revenue stream. Novo Nordisk has launched a new subscription-style pricing model for its weight-loss drug, Wegovy, offering lower costs only to those who commit to multi-month plans. This 'Netflix-style' approach to medicine is a disturbing development that further commodifies human health and creates a two-tiered system of 'premium citizenship.'
Under this model, those who can afford the long-term commitment receive the benefits of modern science, while the poor are left with generic alternatives or nothing at all. This is not the practice of medicine as a vocation of healing; it is the enclosure of the medical commons. When a person's metabolic health becomes a subscription service, we have reached a level of technological alienation that should give us all pause.
We must ask what it does to the soul of a nation when even our physical well-being is mediated through the same financial structures as our television habits. Health is a gift to be stewarded, not a product to be licensed. As we move further into this 'Ghost Era' of simulated reality and automated life, we must fight to maintain the dignity of the physical person. The family doctor should be a trusted guide, not a salesperson for a multi-year pharmaceutical contract.